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Abstract  
 
Background 
The elderly account for an increasing proportion of the population and have a high 
prevalence of coronary heart disease. Percutaneous coronary intervention (PCI) is the 
most common method of revascularisation in the elderly. We examined whether the 
risk of peri-procedural complications following PCI was higher among elderly (≥75 
years) patients and whether it has changed over time.  
 
Methods and Results  
The Scottish Coronary Revascularisation Register was used to undertake a 
retrospective cohort study on all 31,758 patients undergoing non-emergency PCI in 
Scotland between April 2000 and March 2007 inclusive.  There was an increase in the 
number and percentage of PCIs undertaken in elderly patients, from 196 (8.7%) in 
2000 to 752 (13.9%) in 2007. Compared with younger patients, the elderly were more 
likely to have multi-vessel disease, multiple comorbidity and a past history of 
myocardial infarction or coronary artery bypass grafting (χ2 tests, all p<0.001). The 
elderly had a higher risk of major adverse cardiovascular events within 30 days of PCI 
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(4.5% versus 2.7%, χ2 test p<0.001). Over the seven years, there was a significant 
increase in the proportion of elderly patients who had multiple comorbidity (χ2 test for 
trend, p<0.001). In spite of this, the underlying risk of complications did not change 
significantly over time either among the elderly (χ2 test for trend, p=0.142) or overall 
(χ2 test for trend, p=0.083).    
Conclusions 
Elderly patients have a higher risk of peri-procedural complications and account for 
an increasing proportion of PCIs. Despite this, the risk of complications following 
PCI has not increased over time.    
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Introduction  
 
The prevalence of coronary heart disease increases with age. In line with other 
developed countries, the elderly account for an increasing proportion of the Scottish 
population, due to a combination of reduced fertility rates and increased life expectancy. 
Therefore, elderly patients represent an increasing proportion of those presenting for 
cardiovascular investigation and treatment. Previous studies have suggested that elderly 
patients are at greater risk of complications following percutaneous coronary 
intervention (PCI).1-4 The past decade has seen the adoption into clinical practice of 
many developments shown to be effective at improving outcomes and reducing 
complications such as coronary stents, trans-radial access and adjuvant drug 
therapies.2,5-9 Clinical trials have tended to exclude elderly patients.5 Those studies that 
have included elderly patients suggest that the absolute benefit of these developments 
may be even higher in the elderly due to their high baseline risk.5,9 The aim of this study 
was to examine whether the risk of peri-procedural complications following PCI is 
higher among elderly (≥75 years) patients than younger patients and whether it has 
changed over time.  
 
 
Methods 
 
Data sources and inclusion criteria 
The Scottish Coronary Revascularisation Register collects comprehensive, prospective 
information on all patients undergoing PCI in Scotland, including demographic 
characteristics, postcode of residence, cardiac disease severity, co-morbidity, procedure 
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details, past medical and surgical history, and in-hospital complications 
(http://www.scs-online.org.uk/cardreg.php). The Scottish Morbidity Record (SMR1) 
collects information on all admissions to acute hospitals in Scotland, including disease 
and procedure codes (http://www.datadictionaryadmin.scot.nhs.uk/isddd/9065.html). 
The General Registrar for Scotland (GROS) collates death certificate data across 
Scotland, including cause of death. Diseases are recorded using the International 
Classification of Diseases (ICD) and procedures using the Operating Procedure Codes 
(OPCS). The revascularisation register is linked annually to the SMR1 and death 
certificate data at an individual level, providing information on fatal and non-fatal 
events that occur following discharge. Our cohort comprised all patients who underwent 
non-emergency PCI in Scotland between April 2000 and March 2007 inclusive. The last 
linkage undertaken prior to our study provided follow-up events up to 27 June 2007.  
 
Definitions 
Elderly was defined as ≥75 years of age. Obesity was defined as a body mass index 
(BMI) greater than 30. Diabetes included both type I and type II diabetics. Hypertension 
was defined as systolic blood pressure ≥140mmHg, diastolic blood pressure ≥90mmHg 
or anti-hypertensive therapy. Non-cardiac arteriopathy included peripheral arterial 
disease, previous stroke, recurrent transient ischaemic attacks and carotid stenosis 
≥70%. Impaired renal function was defined as serum creatinine >200mmol/l or use of 
renal replacement therapy. Impaired left ventricular function was defined as am ejection 
fraction of <50%. Multiple co-morbidity was defined as the presence of two or more of 
these conditions. Socioeconomic status was measured using the Scottish Index of 
Multiple Deprivation (SIMD) (http://www.scotland.gov.uk/Topics/Statistics/SIMD/). 
The SIMD is derived from 37 indicators across 7 domains (income, employment, 
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health, education, skills and training, housing, geographic access and crime) and is used 
to rank data zones of residence (mean population of 750). The rankings have been used 
to produce deprivation quintiles for the general population which could then be applied 
to our study cohort using their postcode of residence. Peri-procedural outcomes were 
defined as events that occured either in-hospital or post discharge up to 30 days 
following PCI. The binary outcomes studied were all-cause death, fatal/non-fatal 
myocardial infarction and cardiac surgery, as well as the composite outcome of major 
adverse cardiovascular event (MACE) which was defined as being any of the above 
individual outcomes. Routine troponin measurement has not been adopted across 
Scotland. Peri-procedural MI was defined as EKG evidence of a Q wave MI over the 
whole study period. We also studied target vessel revascularisation (TVR) as a 
secondary outcome. This was defined as a repeat coronary revascularisation procedure, 
whether PCI or coronary artery bypass graft, undertaken on the same vessel as the 
original procedure.  
 
Statistical analyses 
The seven years of data were combined to compare binary case-mix variables in elderly 
and younger patients using χ2 tests. The overall risk of adverse outcomes was compared 
using univariable and multivariable binary logistic regression models. In the latter, we 
adjusted for the potential confounding effects of sex, deprivation quintile, BMI, 
comorbidities, smoking status and disease severity. Changes in case-mix and crude 
outcomes over time were analysed using χ2 tests for trend (linear-by-linear association) 
or Cuzick’s test for trend10 for variables that did not satisfy the assumptions of the χ2 
test for trend (linear by linear). Multivariable binary logistic regression analysis was 
performed including an interaction term for age-group and year of procedure, in order to 
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determine whether the association between age-group and outcome changed over time 
after adjusting for the potential confounding factors listed above. The goodness of fit of 
the models was assessed using Hosmer and Lemeshow’s test applied to 8, 10 and 12 
groups of observed and predicted MACE. The analyses were undertaken using SPSS 
15.0 and STATA 10.  
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Results  
 
Overall comparison  
Of the 35,888 patients who underwent PCI in Scotland between 2000 and 2007, 31,758 
(88.9%) were classed as non-emergencies. Of these, 3,513 (11.1%) were performed in 
elderly patients and 28,245 (88.9%) in younger patients. Compared with younger 
patients, the elderly were more likely to be female, have multi-vessel disease, have 
multiple comorbidity, and have a past medical history of acute myocardial infarction or 
coronary artery bypass grafting (Table 1). Of the 31,758 patients, 567 (1.8%) were 
excluded from the outcome analysis because of missing or incomplete follow-up data. 
The missing patients were comparable to those included in the analysis in terms of the 
percentage of elderly (11.4% versus 12.4%, p=0.770) and male (72.1% versus 69.9%, 
p=0.251) patients. In the remaining cohort of 31,191 (98.2%) patients, the overall crude 
risk of MACE within 30 days of PCI was 4.5% in the elderly compared with 2.7% in 
younger patients (Pearson’s χ2 test, p<0.001) (Table 2). Elderly patients had an 
increased risk of both death and myocardial infarction but there was no significant 
difference in the risk of surgery or TVR (Table 2). In the overall logistic regression 
model, the increased risk of MACE among the elderly (unadjusted OR 1.74, 95% CI 
1.46–2.08, p<0.001) was attenuated after adjustment for differences in case-mix 
(gender, smoking status, multi-vessel disease, obesity, hypertension, extra-cardiac 
arteriopathy, renal impairment, left ventricular dysfunction, and deprivation), but 
remained statistically significant (adjusted OR 1.52, 95% CI 1.17–1.98, p<0.001).  
 
Time-trends 
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The overall number of non-emergency PCI procedures performed each year more than 
doubled, from 2,254 in 2000 to 5,522 in 2006 (Figure 1). Thereafter, the number fell 
slightly to 5,427 in 2007, mainly due to a reduction in procedures among younger 
patients. The absolute number of PCIs performed on the elderly increased from 196 in 
2000 to 752 in 2007. The incidence of PCI among the elderly general population 
increased from 56/100,000 per annum in 2000 to 216/100,000 per annum in 2007. 
Among the general population aged 35-74 years, the incidence of PCI increased from 
80/100,000 per annum to 192/100,000 per annum.  
 
The elderly accounted for an increasing proportion of non-emergency PCIs, from 8.7% 
in 2000 to 13.9% in 2007 (χ2 test for trend (linear-by-linear association), p <0.0001). 
Among elderly patients, there was a significant increase in the prevalence of 
comorbidity due to diabetes and renal impairment (Table 3). There was a four-fold 
increase in multiple comorbidity in elderly patients, compared with only a two-fold 
increase in younger patients. The elderly were also characterised by increasing severity 
of cardiac disease with the prevalence of left ventricular dysfunction increasing from 
37.7% to 55.4% (χ2 test for trend (linear-by-linear association), p<0.001). The 
prevalence of multi-vessel disease remained the same in the elderly, compared with a 
16.5% fall in younger patients.     
 
The crude risk of MACE did not change significantly over time among either elderly or 
younger patients (χ2 test for trend (linear-by-linear association), both p<0.0001) (Table 
4) or overall (χ2 test for trend (linear-by-linear association), both p<0.0001). In the 
multivariable binary logistic regression analysis, there was no significant interaction 
between year of procedure and age-group (p=0.967), suggesting that the association 
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between age and outcome did not change significantly over time. The Hosmer and 
Lemeshow tests confirmed that the model was a good fit (8 groups p=0.598, 10 groups 
p=0.605, 12 groups p=0.667). 
 
Discussion  
 
Our results suggest that elderly patients have a higher risk profile and more adverse 
events, and that they account for an increasing number and proportion of non-
emergency PCIs. Our findings add to the existing evidence from previous studies, 
focused on in-hospital events, that have reported a 4-5 fold increased risk of death,2,4 
and a 4-6 fold increased risk of MACE,1-3 among elderly patients. The dramatic increase 
in numbers of PCI over time suggests a change in patient selection. Among elderly 
patients, the worsening case-mix suggests that PCI may now be used for patients who 
previously underwent surgery or were considered unfit for intervention. Among 
younger patients, the proportion with multi-vessel disease fell, suggesting that the 
increasing number may reflect use of PCI in less severe cases that may previously have 
been treated by medical therapy only. In spite of these trends, we demonstrated that, 
over time, the risk of adverse events has not increased either in the elderly or overall. 
Over the period studied many technical developments, new devices and adjuvant 
therapies, have been shown to be effective at improving PCI outcomes,2,5-9 and have 
adopted into routine clinical practice in Scotland, as elsewhere. For example, over the 
period studied, deployment of coronary stents increased from 64% to 90% among 
elderly patients (64% to 94% among younger patients) and the use of ticlopidine or 
clopidogrel increased from 8.2% to 63% among elderly patients (10% to 66% among 
younger patients). In 2000, radial access was used in <5% of patients. In 2000, it was 
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used in 40% patients (both elderly and younger). Our findings suggest that these 
advances have been sufficient to offset the effect of worsening risk profiles among 
patients. 
 
Our cohort comprised all patients undergoing PCI in Scottish NHS hospitals, not a 
selected sample and therefore avoids selection bias. The registry data are detailed and 
comprehensive, and are collected prospectively by clinical staff at the patient’s hospital. 
Most studies have only been able to report in-hospital complications.1-4, 9 This has the 
potential to introduce bias since length of stay in hospital is longer in elderly patients2 
and has fallen over time due to an increase in day-case procedures.11 Through linkage to 
routine data we were able to obtain outcomes up to 30-days of follow-up in both the 
elderly and younger patients. In Scotland, the follow-up information derived from 
SMR1 has been shown to be as complete and accurate as that obtained using 
conventional follow-up methods.12 Unlike previous studies,1-6,9 we excluded patients 
presenting with myocardial infarction since the use of primary and rescue PCI has 
significantly increased over time13 and varies by age14.    
 
In any cohort study, there is always the potential for loss to follow-up due, for example 
due to migration from Scotland. However, this is less likely to occur with 30 day 
outcomes than long-term outcomes. The vast majority of patients were successfully 
linked to the follow-up databases. Only two percent could not be linked but there is no 
reason to suspect a systematic bias in the success of linkage, and analysis confirmed no 
significant statistical differences according to whether or not linkage was achieved.  
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Conclusions 
 
The increasing percentage of elderly in the general population is expected to continue 
until at least 2031,15 suggesting that the need for PCI in the elderly will continue to 
increase. This demographic trend, together with changes in patient selection and case-
mix, will increase the underlying risk of peri-procedural complications. Our 
retrospective study suggests that, so far, we have managed to offset this effect, 
presumably as a result of technical improvements and the adoption of new devices and 
adjuvant therapies. However, further developments may be required if we are to avoid 
worsening outcomes in the future.    
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Table 1. Comparison of characteristics of patients undergoing non-emergency percutaneous coronary 
intervention by age-group.   
 
 
  
≥75 years 
 
<75 years 
 
P value* 
 n (%) 
 
n (%)  
 
Male 
 
2,062 (58.7) 
 
20,151 (71.3) 
 
<0.0001 
Current smoker 1,122 (35.7) 8,284 (32.2) <0.0001 
Multi-vessel disease  1,899 (55.5) 11,041 (40.2) <0.0001 
Obese 457 (19.1) 6,005 (31.4) <0.0001 
Diabetes mellitus 631 (18.6) 4,879 (17.8) 0.228 
Hypertension 1,780 (55.8) 11,877 (45.9) <0.001 
Extra-cardiac arteriopathy 478 (16.0) 2,263 (9.4) <0.001 
Renal impairment  91 (3.0) 330 (1.3) <0.001 
Left ventricular dysfunction  1,644 (52.6) 10,845 (42.5) <0.001 
Multiple comorbidity 629 (17.9) 3,875 (13.7) <0.001 
Previous PCI 481 (15.0) 4,130 (15.7) 0.277 
Previous CABG 547 (16.6) 2,861 (10.7) <0.001 
Previous AMI 1,353 (38.5) 9,623 (34.1) <0.001 
Family history 
 
807 (26.0) 10,974 (42.9) <0.001 
 
*Pearson’s χ2  test  
n number, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, AMI acute 
myocardial infarction 
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Table 2. Comparison of crude 30 day outcomes following non-emergency percutaneous coronary 
intervention by age-group    
 
 
*Pearson’s χ2  test  
 
 
 
 
 
 
  
≥75 years 
 
<75 years 
 
P value* 
 n (%) 
 
n (%)  
 
All-cause death 
 
57 (1.7) 
 
154 (0.6) 
 
<0.001 
AMI 114 (3.3) 546 (2.0) <0.001 
Cardiac surgery 155 (0.6) 19 (0.6) 0.954 
MACE 156 (4.5) 734 (2.7) <0.001  
TVR 47 (1.1) 309 (1.1) 0.193 
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 Table 3. Time trends in case-mix of patients undergoing non-emergency percutaneous coronary intervention by age-group.  
 
   
2000 
 
2001 
 
2002 
 
2003 
 
2004 
 
2005 
 
2006 
 
2007 
 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) P value* 
 
≥75 years 
 male 124 (63.3) 130 (59.6) 141 (52.2) 212 (54.5) 257 (60.2) 340 (61.1) 418 (61.1) 440 (58.5) 0.485 
 current smoker 65 (44.5) 84 (42.9) 85 (35.6) 127 (38.8) 130 (31.9) 208 (38.0) 310 (33.9) 213 (32.0) 0.001 
 multi-vessel disease  85 (59.0) 115 (55.6) 140 (52.4) 212 (55.5) 244 (55.6) 312 (56.0) 384 (56.6) 407 (54.5) 0.098 
 obesity 39 (30.2) 30 (18.1) 31 (16.2) 53 (21.5) 51 (19.0) 68 (17.3) 87 (17.7) 98 (19.5) 0.126 
 diabetes mellitus 61 (31.4) 31 (14.8) 44 (16.5) 64 (17.3) 86 (20.0) 77 (13.8) 121 (18.4) 147 (21.0) <0.001 
 hypertension 46 (31.3) 78 (39.4) 103 (43.6) 177 (51.5) 212 (51.5) 327 (59.6) 403 (64.2) 434 (63.9) 0.173 
 extra-cardiac arteriopathy 11 (5.6) 33 (15.1) 33 (12.2) 60 (15.7) 48 (10.8) 66 (11.7) 103 (15.1) 124 (16.5) 0.062 
 renal impairment  0 (0.0) 7 (4.3) 9 (7.7) 9 (9.9) 8 (8.8) 13 (14.3) 21 (23.1) 20 (22.0) <0.001 
 left ventricular dysfunction  55 (37.7) 106 (51.2) 124 (46.8) 203 (53.4) 240 (55.3) 279 (54.1) 291 (52.9) 346 (55.4) 0.001 
 multiple comorbidity 12 (6.1) 29 (13.3) 35 (13.0) 61 (16.0) 70 (15.7) 107 (19.0) 150 (21.9) 165 (21.9) <0.001 
 previous PCI 24 (15.8) 34 (16.4) 47 (17.9) 57 (16.6) 53 (12.8) 82 (14.9) 91 (14.6) 93 (14.0) 0.134 
 previous CABG 27 (19.6) 29 (14.0) 46 (17.4) 72 (19.5) 67 (15.5) 93 (16.6) 90 (14.0) 123 (18.2) 0.709 
 previous AMI 58 (29.6) 101 (46.3) 132 (48.9) 159 (41.5) 166 (37.3) 221 (39.1) 256 (37.4) 260 (34.6) 0.009 
 family history 73 (50.7) 60 (30.8) 54 (23.6) 81 (25.2) 88 (22.3) 141 (26.1) 151 (24.5) 159 (23.9) <0.001 
           
<75 years 
 male 1,290 (67.2) 1,854 (68.3) 2,132 (70.7) 2,385 (72.4) 2,609 (72.3) 2,958 (71.5) 3,431 (70.9) 3,375 (72.2) 0.023 
 current smoker 705 (45.2) 829 (37.0) 835 (31.2) 923 (30.5) 985 (28.9) 1,305 (32.4) 1,435 (31.4) 1,267 (29.8) <0.001 
 multi-vessel disease  847 (53.2) 1,026 (40.5) 1,061 (35.7) 1,223 (37.5) 1,473 (41.5) 1,656 (40.4) 1,920 (39.8) 1,835 (39.4) <0.001 
 obesity 362 (25.5) 567 (30.1) 637 (30.8) 647 (30.1) 576 (28.9) 946 (32.9) 1,185 (33.7) 1,085 (33.7) <0.001 
 diabetes mellitus 612 (30.2) 429 (16.9) 472 (16.9) 519 (16.3) 569 (16.0) 626 (15.4) 879 (18.6) 773 (17.6) <0.001 
 hypertension 595 (37.7) 916 (40.4) 1,015 (37.8) 1,300 (42.4) 1,450 (42.3) 2,005 (49.7) 2,403 (52.5) 2,193 (51.6) <0.001 
 extra-cardiac arteriopathy 97 (4.7) 222 (8.5) 246 (8.2) 276 (8.4) 250 (6.9) 336 (8.1) 434 (9.0) 402 (8.6) 0.013 
 renal impairment  3 (1.2) 6 (2.4) 2 (0.7) 3 (0.9) 12 (3.3) 6 (1.4) 22 (3.7) 13 (1.9) 0.025 
 left ventricular dysfunction  559 (35.1) 1,029 (41.1) 1,180 (40.1) 1,412 (43.5) 1,412 (40.2) 1,603 (41.8) 1,691 (42.1) 1,959 (48.9) <0.001 
 multiple comorbidity 162 (7.9) 313 (12.0) 360 (11.9) 415 (12.6) 453 (12.6) 616 (15.3) 788 (16.3) 730 (15.6) <0.001 
 previous PCI 331 (20.2) 439 (18.1) 569 (19.3) 440 (14.4) 453 (13.1) 541 (13.4) 696 (15.2) 661 (15.7) <0.001 
 previous CABG 211 (13.3) 334 (13.7) 339 (11.4) 371 (11.7) 358 (10.1) 425 (10.4) 427 (9.2) 396 (9.4) <0.001 
 previous AMI 597 (29.0) 992 (37.9) 1,148 (38.1) 1,251 (38.0) 1,214 (33.6) 1,390 (33.6) 1,635 (33.8) 1,396 (29.5) <0.001 
 family history 769 (49.4) 1,076 (48.3) 1,122 (42.2) 1,229 (41.1) 1,319 (39.0) 1,801 (44.8) 1,987 (43.6) 1,671 (39.6) <0.001 
           
 
*χ2 test for trend (linear-by-linear association) 
n number, PCI percutaneous coronary intervention, CABG coronary artery bypass grafting, AMI acute myocardial infarction  
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Table 4. Time trends in crude 30 day outcomes following non-emergency percutaneous coronary intervention by age-group.  
 
 
 
 
 
   
2000 
 
2001 
 
2002 
 
2003 
 
2004 
 
2005 
 
2006 
 
2007 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
 
 
P value* 
 
 
≥75 years 
  n=192 n=202 n=267 n=377 n=442 n=560 n=679 n=730  
 All-cause death 2 (1.0) 2 (1.0) 4 (1.5) 6 (1.6) 10 (2.3) 7 (1.3) 10 (1.5) 16 (2.1) 0.780 
 AMI 1 (0.5) 7 (3.5) 6 (2.3) 15 (4.0) 13 (2.9) 20 (3.7) 25 (3.7) 27 (3.7) 0.792 
 Cardiac surgery 2 (1.0) 0 (0.0) 2 (0.8) 1 (0.3) 2 (0.9) 4 (0.7) 3 (0.4) 3 (0.4) 0.667 
 MACE 5 (2.6) 7 (3.5) 10 (3.7) 18 (4.8) 20 (4.5) 29 (5.2) 31 (4.6) 36 (4.9) 0.142 
 TVR  
 
3 (1.6) 3 (1.5) 6(2.2) 7(1.9) 4(0.9) 13(2.3) 17 (2.5) 11 (1.5) 0.711 
<75 years 
  n=1,982 n=2,475 n=2,976 n=3,269 n=3,550 n=4,095 n=4,813 n=4,582  
 All-cause death 10 (0.5) 10 (0.4) 12 (0.4) 18 (0.6) 26 (0.7) 27 (0.7) 26 (0.5) 25 (0.6) 0.349 
 AMI 25 (1.7) 34 (1.4) 54 (1.8) 65 (2.0) 83 (2.3) 98 (2.3) 104 (2.2) 83 (1.8) 0.024 
 Cardiac surgery 11 (1.1) 21 (0.8) 16 (0.5) 22 (0.6) 23 (0.6) 25 (0.6) 15 (0.3) 22 (0.5) 0.041 
 MACE 42 (2.2) 58 (2.4) 72 (2.5) 90 (2.8) 111 (3.2) 127 (3.2) 127 (2.7) 107 (2.4) 0.405 
 TVR  
 
23 (1.2) 39 (1.6) 53 (1.8) 62 (1.9) 61 (1.7) 79 (1.9) 74(1.5) 73(1.6) 0.660 
 
* Cuzick’s test for trend10 for cardiac surgery in elderly; χ2  test for trend (linear-by-linear association) in the remainder 
n number, AMI acute myocardial infarction, MACE major adverse cardiovascular event, TVR target vessel revascularisation  
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Figure 1. Numbers of non-emergency percutaneous coronary interventions per annum by age-
group.        
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